Research & Development

What Is the Future of Modern Oncology and Cancer Treatment?
Research & Development What Is the Future of Modern Oncology and Cancer Treatment?

The staggering realization that nearly twenty million individuals receive a cancer diagnosis annually across the globe has catalyzed a shift from generalized medical protocols toward highly nuanced, patient-specific interventions. In the United States alone, the National Cancer Institute tracks

Is Your Oral Health a Warning Sign for Colon Cancer?
Research & Development Is Your Oral Health a Warning Sign for Colon Cancer?

Recent clinical investigations suggest that the traditional boundary between dental hygiene and systemic wellness is rapidly dissolving as researchers identify startling connections between gum disease and digestive malignancies. While most people view a routine dental cleaning as a simple cosmetic

Medicus Pharma Reports Strong Phase 2 Skin Cancer Trial Data
Research & Development Medicus Pharma Reports Strong Phase 2 Skin Cancer Trial Data

Basal cell carcinoma remains the most frequently diagnosed form of cancer globally, yet the primary treatment still relies on invasive surgery that often leaves patients with significant scarring and long recovery times. This reality has prompted a search for non-surgical interventions that provide

US Health Insurers Fail to Deliver on Reform Pledges
Research & Development US Health Insurers Fail to Deliver on Reform Pledges

Ivan Kairatov is a preeminent biopharma and health policy expert with a distinguished career spanning drug development, clinical research, and navigating the complexities of the American insurance landscape. With his deep technical background in innovation and a keen understanding of the

ACC and AHA Release New 2026 Dyslipidemia Management Guidelines
Research & Development ACC and AHA Release New 2026 Dyslipidemia Management Guidelines

A silent transformation is currently reshaping the landscape of preventive cardiology as clinical focus pivots from reacting to heart attacks toward intercepting the microscopic origins of arterial decay. This shift is codified in the latest clinical standards issued by the American College of

How Can SonoPIN Revolutionize Intracellular Drug Delivery?
Research & Development How Can SonoPIN Revolutionize Intracellular Drug Delivery?

The primary obstacle to curing many aggressive forms of cancer is not a lack of potent chemical agents but rather the physical inability to smuggle these treatments past the cellular gatekeepers of the body. Most revolutionary therapies, designed to dismantle the very foundation of a tumor, are

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later